Literature DB >> 24445916

PTPN2 attenuates T-cell lymphopenia-induced proliferation.

Florian Wiede1, Nicole L La Gruta2, Tony Tiganis1.   

Abstract

When the peripheral T-cell pool is depleted, T cells undergo homoeostatic expansion. This expansion is reliant on the recognition of self-antigens and/or cytokines, in particular interleukin-7. The T cell-intrinsic mechanisms that prevent excessive homoeostatic T-cell responses and consequent overt autoreactivity remain poorly defined. Here we show that protein tyrosine phosphatase N2 (PTPN2) is elevated in naive T cells leaving the thymus to restrict homoeostatic T-cell proliferation and prevent excess responses to self-antigens in the periphery. PTPN2-deficient CD8(+) T cells undergo rapid lymphopenia-induced proliferation (LIP) when transferred into lymphopenic hosts and acquire the characteristics of antigen-experienced effector T cells. The enhanced LIP is attributed to elevated T-cell receptor-dependent, but not interleukin-7-dependent responses, results in a skewed T-cell receptor repertoire and the development of autoimmunity. Our results identify a major mechanism by which homoeostatic T-cell responses are tuned to prevent the development of autoimmune and inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24445916     DOI: 10.1038/ncomms4073

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  30 in total

Review 1.  Innate memory T cells.

Authors:  Stephen C Jameson; You Jeong Lee; Kristin A Hogquist
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

Review 2.  Homeostatic expansion as a barrier to lymphocyte depletion strategies.

Authors:  Nicholas A Zwang; Laurence A Turka
Journal:  Curr Opin Organ Transplant       Date:  2014-08       Impact factor: 2.640

Review 3.  Role of protein tyrosine phosphatases in regulating the immune system: implications for chronic intestinal inflammation.

Authors:  Marianne R Spalinger; Declan F McCole; Gerhard Rogler; Michael Scharl
Journal:  Inflamm Bowel Dis       Date:  2015-03       Impact factor: 5.325

4.  miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines.

Authors:  Yun Ji; Claudia Wrzesinski; Zhiya Yu; Jinhui Hu; Sanjivan Gautam; Nga V Hawk; William G Telford; Douglas C Palmer; Zulmarie Franco; Madhusudhanan Sukumar; Rahul Roychoudhuri; David Clever; Christopher A Klebanoff; Charles D Surh; Thomas A Waldmann; Nicholas P Restifo; Luca Gattinoni
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-29       Impact factor: 11.205

Review 5.  Functional heterogeneity and adaptation of naive T cells in response to tonic TCR signals.

Authors:  Joel Eggert; Byron B Au-Yeung
Journal:  Curr Opin Immunol       Date:  2021-10-12       Impact factor: 7.486

6.  Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.

Authors:  Elif Karaca Atabay; Carmen Mecca; Qi Wang; Chiara Ambrogio; Ines Mota; Nina Prokoph; Giulia Mura; Cinzia Martinengo; Enrico Patrucco; Giulia Leonardi; Jessica Hossa; Achille Pich; Luca Mologni; Carlo Gambacorti-Passerini; Laurence Brugières; Birgit Geoerger; Suzanne D Turner; Claudia Voena; Taek-Chin Cheong; Roberto Chiarle
Journal:  Blood       Date:  2022-02-03       Impact factor: 22.113

7.  PTP1B Is an Intracellular Checkpoint that Limits T-cell and CAR T-cell Antitumor Immunity.

Authors:  Florian Wiede; Kun-Hui Lu; Xin Du; Mara N Zeissig; Rachel Xu; Pei Kee Goh; Chrysovalantou E Xirouchaki; Samuel J Hogarth; Spencer Greatorex; Kevin Sek; Roger J Daly; Paul A Beavis; Phillip K Darcy; Nicholas K Tonks; Tony Tiganis
Journal:  Cancer Discov       Date:  2022-03-01       Impact factor: 38.272

8.  PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis.

Authors:  M R Spalinger; S Kasper; C Chassard; T Raselli; I Frey-Wagner; C Gottier; S Lang; K Atrott; S R Vavricka; F Mair; B Becher; C Lacroix; M Fried; G Rogler; M Scharl
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

Review 9.  Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease.

Authors:  Marianne R Spalinger; Declan F McCole; Gerhard Rogler; Michael Scharl
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

10.  Targeting Protein Tyrosine Phosphatase 22 Does Not Enhance the Efficacy of Chimeric Antigen Receptor T Cells in Solid Tumors.

Authors:  Xin Du; Phillip K Darcy; Florian Wiede; Tony Tiganis
Journal:  Mol Cell Biol       Date:  2022-01-18       Impact factor: 5.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.